Cai W, Zhang H, Wu Y, Yao Y, Zhang J. Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer's disease: a systematic review and network meta-analysis of randomized controlled trials. Front Aging Neurosci. 2024;16:1465871. Epub 2025 Jan 29 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.